Targeting of colorectal cancer organoids with zoledronic acid conjugated to the anti-EGFR antibody cetuximab
Roberto Benelli(Ospedale Policlinico San Martino), Alessandro Poggi(Ospedale Policlinico San Martino)
Cited by 24
Related Papers
SIRT6 inhibitors with salicylate-like structure show immunosuppressive and chemosensitizing effects
|Bioorganic & Medicinal Chemistry|2017|49
The chemopreventive retinoid 4HPR impairs prostate cancer cell migration and invasion by interfering with FAK/AKT/GSK3β pathway and β-catenin stability
|Molecular Cancer|2010|48
Response to ipilimumab therapy in metastatic melanoma patients: potential relevance of CTLA-4+ tumor infiltrating lymphocytes and their in situ localization
|Cancer Immunology Immunotherapy|2020|25